Corporate January 20, 2022 IntegriChain and Blue Fin Group Combine Forces 2 Minute Read Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.
Launch Readiness January 19, 2022 Best Practices: Redesigning the Perfect Launch 3 Minute Read We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
Channel January 13, 2022 Frequently Asked Questions: Channel and Revenue Leakage 3 Minute Read We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.
Channel December 20, 2021 Retail Pharmacy’s Digital Transformation 3 Minute Read As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?
ICyte Platform November 23, 2021 A Look Back at the 2021 Access Insights Conference 2 Minute Read Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.
Contracts & Pricing November 23, 2021 Regulatory Updates 4 Minute Read This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.
ICyte Platform October 29, 2021 15 Years Strong 2 Minute Read Founder and CEO Kevin Leininger celebrates IntegriChain's outstanding customers and our team of professionals around the globe on our 15th anniversary.
Contracts & Pricing October 20, 2021 The New Plan for Addressing High Drug Prices 4 Minute Read We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.
Government Pricing October 11, 2021 Frequently Asked Questions: 340B Program 3 Minute Read Examining common questions about the 340B program and what ICyte solutions are available to identify and act on non-compliance.
